FOUND: 2 - What They Never Told You

Viking Therapeutics: Could GLP-1 Maker Be Acquired Pre-Approval?

Viking Therapeutics stock jumped on rumors of a potential acquirer looking to add a GLP-1 treatment to their portfolio and VK2735 appears to rival Zepbound.

MarketBeat · Feb 26, 2025

2 'Strong Buy' Biotech Stocks With 120% or More Upside Potential

With the growing demand for cutting-edge therapies reshaping the healthcare landscape, here are two “Strong Buy”-rated biotech stocks with significant potential upside.

Barchart · Dec 8, 2024

Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data

Viking Therapeutics stock is volatile Monday after the pharma company released positive data for its weight-loss drug. Here's what you need to know.

Kiplinger · Nov 4, 2024

5 Breakout Biotech Stocks Leading the Russell 2000 Higher

These small-cap biotech stocks are rallying hard in 2024, and still have room to keep leading the RUT higher.

Barchart · May 23, 2024

3 'Strong Buy' Growth Stocks to Scoop Up Now

High-growth stocks, such as cybersecurity name Zscaler, could be part of your equity portfolio in 2024 - if you're the type of investor who can successfully stomach massive drawdowns in share prices and valuations.

Barchart · Mar 25, 2024

5 Russell 2000 Stocks Outperforming the 'Magnificent Seven' in 2024

The "Magnificent Seven" have lost some momentum in 2024, just as small-caps are starting to come on strong. Here's a closer look at five Russell 2000 stocks that are crushing the performance of their mega-cap peers so far this year.

Barchart · Mar 13, 2024

Up 283% YTD, Is It Too Late to Buy Viking Therapeutics Stock?

Shares of Viking Therapeutics have been on an absolute tear in 2024, as the biotech stock gears up to enter the weight-loss drug market.

Barchart · Mar 8, 2024

Stock Market Today: Stocks End Mixed After Disappointing Economic Data

The main indexes made muted moves Tuesday as investors took data that showed a big drop in durable goods and consumer confidence.

Kiplinger · Feb 27, 2024